← Back to Valiant Laboratories Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

VALIANTLABPharmaceuticals

Valiant Laboratories Ltd — Financial Ratios & Key Metrics

₹51.62

-5.74%

P/E Ratio72.54xIndustry: 31.77x

ROE-1.43%Return on equity

ROCE-0.95%Return on capital

Debt/Equity0.17Low debt

💎

Valuation & Profitability

P/E Ratio

72.54x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹367.80 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

-18.12%

3 Months

-21.87%

6 Months

-32.32%

1 Year

-37.15%

52W Low

₹50

Current

₹52

52W High

₹124

3% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹58

▼ Price below SMA 50 — Bearish

SMA 200

₹80

▼ Long-term downtrend

Volume Signal

113% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Valiant Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.